Dr. Nikolaos Trikalinos
Claim this profileWashington University School of Medicine
Studies Pancreatic Cancer
Studies Cancer
20 reported clinical trials
44 drugs studied
Area of expertise
1Pancreatic Cancer
Stage IV
Stage III
MET positive
2Cancer
Stage IV
Stage III
MET positive
Affiliated Hospitals
Clinical Trials Nikolaos Trikalinos is currently running
Temozolomide + Tuvusertib
for Cancer
This trial tests a combination of two drugs, temozolomide and M1774, in patients with advanced cancer that has spread. Temozolomide damages cancer cell DNA, while M1774 blocks growth enzymes. The goal is to find a more effective treatment for these patients.
Recruiting1 award Phase 1 & 2
Mitotane +/- Cisplatin and Etoposide
for Adrenal Cancer
This phase III trial studies how well mitotane alone works compared to mitotane with cisplatin and etoposide when given after surgery in treating patients with adrenocortical cancer that has a high risk of coming back (recurrence). Cortisol can cause the growth of adrenocortical tumor cells. Antihormone therapy, such as mitotane, may lessen the amount of cortisol made by the body. Drugs used in chemotherapy, such as cisplatin and etoposide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether mitotane alone or mitotane with cisplatin and etoposide after surgery works better in treating patients with adrenocortical carcinoma.
Recruiting2 awards Phase 36 criteria
More about Nikolaos Trikalinos
Clinical Trial Related7 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Nikolaos Trikalinos has experience with
- Nivolumab
- Cabozantinib
- Gemcitabine
- Lutetium Lu 177 Dotatate
- Sunitinib Malate
- FDG PET/MRI
Breakdown of trials Nikolaos Trikalinos has run
Pancreatic Cancer
Cancer
Colorectal Cancer
Rectal Cancer
Pancreatic Neuroendocrine Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nikolaos Trikalinos specialize in?
Nikolaos Trikalinos focuses on Pancreatic Cancer and Cancer. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are Stage III.
Is Nikolaos Trikalinos currently recruiting for clinical trials?
Yes, Nikolaos Trikalinos is currently recruiting for 6 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Nikolaos Trikalinos has studied deeply?
Yes, Nikolaos Trikalinos has studied treatments such as Nivolumab, Cabozantinib, Gemcitabine.
What is the best way to schedule an appointment with Nikolaos Trikalinos?
Apply for one of the trials that Nikolaos Trikalinos is conducting.
What is the office address of Nikolaos Trikalinos?
The office of Nikolaos Trikalinos is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.